BA
AMBI

BlackRock Advisors’s Ambit Biosciences Corp AMBI Stock Holding History

BlackRock Advisors’s Portfolio AMBI Stock Details AMBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,150
Closed -$33K – 3807
2014
Q3 		$33K Sell
2,150
-52,264
-96% -$359K ﹤0.01% 3382
2014
Q2 		$376K Buy
54,414
+4,610
+9% +$32.3K ﹤0.01% 2219
2014
Q1 		$454K Buy
49,804
+32,215
+183% +$342K ﹤0.01% 2115
2013
Q4 		$170K Buy
17,589
+16,416
+1,399% +$219K ﹤0.01% 2747
2013
Q3 		$18K Buy
+1,173
New +$15.6K ﹤0.01% 3344

BlackRock Advisors's AMBI Position: Q4 2014 in Review

BlackRock Advisors sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 2,150 shares — an estimated $33K sold.

BlackRock Advisors first reported a position in AMBI in Q3 2013 and held it in 5 quarters. The position peaked at $454K in Q1 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

  • BlackRock Advisors reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
  • BlackRock Advisors sold 2,150 Ambit Biosciences Corp shares in Q4 2014, an estimated $33K.
  • BlackRock Advisors first reported a position in Ambit Biosciences Corp in Q3 2013 and held it in 5 quarters.
  • BlackRock Advisors's Ambit Biosciences Corp position peaked at $454K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on BlackRock Advisors's 13F filing for Q4 2014, filed 9 Feb 2015.